| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Jennifer P King | Q57079065 |
| Edward A Belongia | Q59829972 | ||
| Maria Sundaram | Q86247747 | ||
| Huong Q McLean | Q92686224 | ||
| Nicholas S. Kelley | Q117481456 | ||
| Michael T. Osterholm | Q3308425 | ||
| P2093 | author name string | Melissa D Simpson | |
| P2860 | cites work | Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities | Q28741469 |
| I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe | Q28742719 | ||
| Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
| Mapping the antigenic and genetic evolution of influenza virus | Q29617255 | ||
| Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
| Estimating influenza vaccine effectiveness using routinely collected laboratory data. | Q30382480 | ||
| Effectiveness of the pandemic influenza A/H1N1 2009 monovalent vaccine in Korea. | Q30398065 | ||
| Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. | Q30399334 | ||
| Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study. | Q30404419 | ||
| Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 | Q30404923 | ||
| Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study. | Q30406619 | ||
| Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
| Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. | Q30410112 | ||
| Assessment of the variability in influenza A(H1N1) vaccine effectiveness estimates dependent on outcome and methodological approach | Q30411303 | ||
| Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study | Q30414952 | ||
| Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom | Q30417900 | ||
| Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season | Q30426206 | ||
| Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study | Q30428316 | ||
| Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: test-negative case-control studies using surveillance data, Spain, 2003-2011. | Q30833500 | ||
| Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates | Q33554684 | ||
| Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 | Q33931144 | ||
| Serologic assays for influenza surveillance, diagnosis and vaccine evaluation | Q34194336 | ||
| Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons | Q34393525 | ||
| Effectiveness of seasonal influenza vaccine in community-dwelling elderly people: a meta-analysis of test-negative design case-control studies | Q34451202 | ||
| Surveillance and vaccine effectiveness of an influenza epidemic predominated by vaccine-mismatched influenza B/Yamagata-lineage viruses in Taiwan, 2011-12 season | Q34614814 | ||
| Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review | Q34778408 | ||
| Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination | Q34993133 | ||
| Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses | Q35130915 | ||
| Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type | Q35531934 | ||
| Evaluation of influenza vaccine effectiveness and description of circulating strains in outpatient settings in South Africa, 2014 | Q35761073 | ||
| Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains | Q36854011 | ||
| Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia | Q38275284 | ||
| Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season | Q38415770 | ||
| The test-negative design for estimating influenza vaccine effectiveness | Q38427246 | ||
| Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | Q21144621 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. | Q40670577 | ||
| Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. | Q41474318 | ||
| Interim influenza vaccine effectiveness: A good proxy for final estimates in Spain in the seasons 2010-2014. | Q42148972 | ||
| Influenza vaccine effectiveness estimates for Western Australia during a period of vaccine and virus strain stability, 2010 to 2012. | Q42187912 | ||
| Influenza vaccine effectiveness against medically-attended influenza illness during the 2012-2013 season in Beijing, China | Q42201843 | ||
| Influenza vaccine effectiveness in Australia: results from the Australian Sentinel Practices Research Network. | Q42205222 | ||
| Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. | Q42227573 | ||
| Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis. | Q42227574 | ||
| Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine | Q42242172 | ||
| Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match | Q42244861 | ||
| Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants | Q45167252 | ||
| Influenza virus surveillance, vaccine strain selection, and manufacture | Q45358113 | ||
| Stratified estimates of influenza vaccine effectiveness by prior vaccination: caution required | Q45375388 | ||
| Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results | Q45848424 | ||
| Effectiveness of trivalent and monovalent influenza vaccines against laboratory-confirmed influenza infection in persons with medically attended influenza-like illness in Bavaria, Germany, 2010/2011 season | Q46200283 | ||
| A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
| Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. | Q48071872 | ||
| Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses | Q48077254 | ||
| Estimates of influenza vaccine effectiveness in primary care in Scotland vary with clinical or laboratory endpoint and method--experience across the 2010/11 season. | Q51174772 | ||
| The case test-negative design for studies of the effectiveness of influenza vaccine. | Q51225150 | ||
| Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. | Q54272482 | ||
| The impact of influenza epidemics on mortality: introducing a severity index. | Q54731473 | ||
| Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection | Q57385728 | ||
| Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study | Q59617109 | ||
| Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children | Q61848833 | ||
| P6195 | funding scheme | grant | Q230788 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza | Q2840 |
| influenza vaccine | Q383260 | ||
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| vaccine engineering | Q14861085 | ||
| infectious disease | Q18123741 | ||
| P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
| P304 | page(s) | 942-951 | |
| P12526 | performing organization | University of Minnesota | Q238101 |
| P577 | publication date | 2016-04-06 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P859 | sponsor | National Institute for Occupational Safety and Health | Q60346 |
| P1476 | title | Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies | |
| P478 | volume | 16 |
| Q55322352 | 'What have you HEARD about the HERD?' Does education about local influenza vaccination coverage and herd immunity affect willingness to vaccinate? |
| Q36991782 | A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season |
| Q90409521 | A Population-Based Propensity Score-Matched Study to Assess the Impact of Repeated Vaccination on Vaccine Effectiveness for Influenza-Associated Hospitalization Among the Elderly |
| Q64137151 | A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness |
| Q92706811 | A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy) |
| Q92247000 | A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm |
| Q45778868 | A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine. |
| Q40239527 | Anti-influenza Activity of a Bacillus subtilis Probiotic Strain |
| Q30400732 | Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice |
| Q92366944 | Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly |
| Q64252855 | Assessing the Dynamics and Control of Droplet- and Aerosol-Transmitted Influenza Using an Indoor Positioning System |
| Q90299458 | Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains |
| Q90342429 | Association between the respiratory microbiome and susceptibility to influenza virus infection |
| Q57093922 | Augmented CD4 T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years |
| Q91955949 | Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission |
| Q50065275 | Beyond Antigenic Match: Moving Toward Greater Understanding of Influenza Vaccine Effectiveness |
| Q47613621 | Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada |
| Q47264095 | Broad Spectrum Inhibitor of Influenza A and B Viruses Targeting the Viral Nucleoprotein. |
| Q59801730 | Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs |
| Q64245361 | Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations |
| Q92915035 | Can routinely collected laboratory and health administrative data be used to assess influenza vaccine effectiveness? Assessing the validity of the Flu and Other Respiratory Viruses Research (FOREVER) Cohort |
| Q57808456 | Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls |
| Q39530697 | Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011. |
| Q64130391 | Caution required in the use of administrative data and general laboratory submissions for influenza vaccine effectiveness estimation |
| Q57480742 | Cell culture-derived influenza vaccines in the severe 2017-2018 epidemic season: a step towards improved influenza vaccine effectiveness |
| Q48011448 | Challenges Remain for Influenza Vaccination of Children |
| Q64108822 | Characteristics of hospitalized adult patients with laboratory documented Influenza A, B and Respiratory Syncytial Virus - A single center retrospective observational study |
| Q57789668 | Characterization of Influenza B Virus Variants with Reduced Neuraminidase Inhibitor Susceptibility |
| Q90242280 | Childhood vaccination against seasonal influenza - is there a risk of undesirable outcomes? |
| Q64054477 | Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: possible cohort effect following the 2009 influenza pandemic |
| Q64087276 | Co-circulation of influenza A(H1N1)pdm09 and influenza A(H3N2) viruses, World Health Organization (WHO) European Region, October 2018 to February 2019 |
| Q92539071 | Combination of STING Pathway Agonist With Saponin Is an Effective Adjuvant in Immunosenescent Mice |
| Q92985604 | Commentary: Test-Negative Design Reduces Confounding by Healthcare-Seeking Attitude in Case-Control Studies |
| Q40280177 | Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012-2013 and 2013-2014. |
| Q92883654 | Comparison of Respiratory Specimen Collection Methods for Detection of Influenza Virus Infection by Reverse Transcription-PCR: a Literature Review |
| Q89869148 | Comparison of antigenic mutation during egg and cell passage cultivation of H3N2 influenza virus |
| Q47552950 | Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16. |
| Q41997569 | Comparison of two control groups for estimation of oral cholera vaccine effectiveness using a case-control study design |
| Q47150783 | Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains. |
| Q38886356 | Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study. |
| Q64102099 | Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages |
| Q33899438 | Different Repeat Annual Influenza Vaccinations Improve the Antibody Response to Drifted Influenza Strains |
| Q40293543 | Does seasonal vaccination affect the clinical presentation of influenza among the elderly? A cross-sectional analysis in the outpatient setting in France, 2003-2014. |
| Q37660781 | Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe |
| Q89759208 | Early prediction of antigenic transitions for influenza A/H3N2 |
| Q49204982 | Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018. |
| Q91524784 | Economic assessment of a high-dose versus a standard-dose influenza vaccine in the US Veteran population: Estimating the impact on hospitalization cost for cardio-respiratory disease |
| Q30391150 | Effect of Statin Use on Influenza Vaccine Effectiveness |
| Q64126062 | Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis |
| Q30403059 | Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain |
| Q64124899 | Effect of propensity of seeking medical care on the bias of the estimated effectiveness of rotavirus vaccines from studies using a test-negative case-control design |
| Q39129072 | Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants |
| Q57093647 | Effective in Vivo Targeting of Influenza Virus through a Cell-Penetrating/Fusion Inhibitor Tandem Peptide Anchored to the Plasma Membrane |
| Q57100369 | Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study |
| Q59349265 | Effectiveness of inactivated influenza vaccine against laboratory-confirmed influenza pneumonia among adults aged ≥65 years in Japan |
| Q90237311 | Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs |
| Q59350861 | Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study |
| Q52689551 | Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16. |
| Q41932605 | Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies |
| Q31161295 | Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies |
| Q92942088 | Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019 |
| Q47397356 | Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials |
| Q92458351 | End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18 |
| Q47154049 | End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17. |
| Q52627557 | Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines. |
| Q89628684 | Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain |
| Q91861593 | Estimated hospitalisations attributable to seasonal and pandemic influenza in Australia: 2001- 2013 |
| Q47363883 | Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016. |
| Q64130596 | Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population |
| Q90927798 | Exploring indirect protection associated with influenza immunization - A systematic review of the literature |
| Q52805071 | Exploring the effect of previous inactivated influenza vaccination on seasonal influenza vaccine effectiveness against medically-attended influenza: results of the European I-MOVE multicentre test-negative case-control study, 2011/12-2016/17. |
| Q56880026 | Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine |
| Q92296564 | Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017-2018 |
| Q64061950 | Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza |
| Q96155819 | Frailty Is Associated With Increased Hemagglutination-Inhibition Titers in a 4-Year Randomized Trial Comparing Standard- and High-Dose Influenza Vaccination |
| Q90148702 | Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines |
| Q47100436 | Genetic and antigenic divergence in the influenza A(H3N2) virus circulating between 2016 and 2017 in Thailand |
| Q38663443 | Genetic divergence of Influenza A(H3N2) amino acid substitutions mark the beginning of the 2016-2017 winter season in Israel |
| Q92482109 | Host Factors Impact Vaccine Efficacy: Implications for Seasonal and Universal Influenza Vaccine Programs |
| Q93158881 | How long are children protected by influenza vaccination? |
| Q59349308 | Immune History and Influenza Vaccine Effectiveness |
| Q47600802 | Immune responses to twice-annual influenza vaccination in older adults in Hong Kong. |
| Q88933799 | Immunodominance hierarchy of influenza subtype-specific neutralizing antibody response as a hurdle to effectiveness of polyvalent vaccine |
| Q57469949 | Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice |
| Q92016365 | Impact of national influenza vaccination strategy in severe influenza outcomes among the high-risk Portuguese population |
| Q38683726 | Inactivated influenza virus vaccines: the future of TIV and QIV. |
| Q89511393 | Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine |
| Q60912736 | Indirect protection from vaccinating children against influenza in households |
| Q64123985 | Influenza |
| Q89880122 | Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA |
| Q30397977 | Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement |
| Q89588663 | Influenza Vaccine Effectiveness among Elementary School Students in Korea during the 2016-2017 Seasons: a Cross-Sectional Survey |
| Q90246622 | Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease |
| Q59352861 | Influenza Vaccine Effectiveness in the United States during the 2016-2017 Season |
| Q40369526 | Influenza vaccination in older people with diabetes and their household contacts |
| Q92193244 | Influenza vaccine effectiveness against hospitalizations in children and older adults-Data from South America, 2013-2017. A test negative design |
| Q47551798 | Influenza vaccine effectiveness against influenza A(H3N2) hospitalizations in children in Hong Kong in a prolonged season, 2016/17. |
| Q89955514 | Influenza vaccine effectiveness against influenza-associated hospitalization in children: A systematic review and meta-analysis |
| Q59351229 | Influenza vaccine effectiveness among patients with high-risk medical conditions in the United States, 2012-2016 |
| Q38835739 | Influenza vaccine effectiveness estimates in the Dutch population from 2003 to 2014: The test-negative design case-control study with different control groups |
| Q54277492 | Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. |
| Q57530834 | Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015 |
| Q59354975 | Influenza vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings: A test-negative case-control study in Beijing, China, 2016/17 season |
| Q40336099 | Influenza vaccine effectiveness using the test-negative design: comparability and methodological challenges in meta-analyses |
| Q47889238 | Influenza vaccine response: future perspectives |
| Q90018307 | Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing |
| Q98898240 | Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution |
| Q54261205 | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies. |
| Q38957414 | Interim Estimates of 2016-17 Seasonal Influenza Vaccine Effectiveness - United States, February 2017. |
| Q49981002 | Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018. |
| Q64243916 | Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019 |
| Q89802120 | Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020 |
| Q54265545 | Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18. |
| Q37652088 | Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. |
| Q61810206 | Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019 |
| Q55499955 | Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks. |
| Q38635123 | Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants? |
| Q59349829 | Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China |
| Q90200906 | La grippe |
| Q47413448 | Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. |
| Q40721623 | Methodological evolution of influenza vaccine effectiveness assessment |
| Q37708550 | Mid-season real-time estimates of seasonal influenza vaccine effectiveness in persons 65 years and older in register-based surveillance, Stockholm County, Sweden, and Finland, January 2017 |
| Q55518397 | Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge. |
| Q90108074 | Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage |
| Q90098455 | Molecular detection of respiratory pathogens and typing of human rhinovirus of adults hospitalized for exacerbation of asthma and chronic obstructive pulmonary disease |
| Q64075985 | Mortality attributable to seasonal influenza in Greece, 2013 to 2017: variation by type/subtype and age, and a possible harvesting effect |
| Q61818413 | Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses |
| Q57094018 | Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness |
| Q37311543 | Neutralizing Antibody Responses to Antigenically Drifted Influenza A(H3N2) Viruses among Children and Adolescents following 2014-2015 Inactivated and Live Attenuated Influenza Vaccination |
| Q90639926 | Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in Mice |
| Q61445049 | OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes |
| Q47709222 | On the bias of estimates of influenza vaccine effectiveness from test-negative studies |
| Q99633060 | Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice |
| Q57793046 | Plasticity of amino acid residue 145 near the receptor binding site of H3 swine influenza A viruses and its impact on receptor binding and antibody recognition |
| Q51151777 | Poor immunogenicity, not vaccine strain egg adaptation, may explain the low H3N2 influenza vaccine effectiveness in 2012-13. |
| Q89998770 | Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza |
| Q91494536 | Post-pandemic influenza A/H1N1pdm09 is associated with more severe outcomes than A/H3N2 and other respiratory viruses in adult hospitalisations |
| Q92519469 | Post-pandemic influenza-associated mortality in Mexico |
| Q90435489 | Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections |
| Q92450354 | Preventing an Antigenically Disruptive Mutation in Egg-Based H3N2 Seasonal Influenza Vaccines by Mutational Incompatibility |
| Q64134459 | Prevention of influenza hospitalization among adults in the US, 2015-16: Results from the US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN) |
| Q90948756 | Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19 |
| Q92690560 | Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model |
| Q64948767 | Randomized controlled trial of influenza vaccine in patients with heart failure to reduce adverse vascular events (IVVE): Rationale and design. |
| Q91938950 | Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses |
| Q90557202 | Reconciling estimates of the global influenza burden |
| Q64130675 | Reduction of influenza A(H3N2)-associated symptoms by influenza vaccination in school aged-children during the 2014-2015 winter season dominated by mismatched H3N2 viruses |
| Q40280348 | Repeated Vaccination Does Not Appear to Impact Upon Influenza Vaccine Effectiveness Against Hospitalization With Confirmed Influenza |
| Q39340731 | Repeated annual influenza vaccination and vaccine effectiveness: review of evidence |
| Q47340934 | Report on eighth WHO meeting on development of influenza vaccines that induce broadly protective and long-lasting immune responses: Chicago, USA, 23-24 August 2016. |
| Q42650298 | Retrospective Observational Study of Atypical Winter Respiratory Illness Season Using Real-Time Syndromic Surveillance, England, 2014-15 |
| Q64964557 | Risk of influenza infection with low vaccine effectiveness: the role of avoidance behaviour. |
| Q64063945 | Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line |
| Q40146222 | Seasonal influenza vaccine effectiveness against laboratory-confirmed influenza hospitalizations - Latin America, 2013. |
| Q99404824 | Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses |
| Q30151372 | Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015. |
| Q57105215 | Significant spike in excess mortality in England in winter 2014/15 - influenza the likely culprit |
| Q93084241 | Structural and antigenic characterization of a computationally-optimized H5 hemagglutinin influenza vaccine |
| Q89723632 | The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65 |
| Q41919202 | The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine |
| Q92084109 | The effectiveness of influenza vaccination in preventing hospitalizations in elderly in Beijing, 2016-18 |
| Q96813808 | The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus |
| Q92640448 | The impact of repeated vaccination using 10-year vaccination history on protection against influenza in older adults: a test-negative design study across the 2010/11 to 2015/16 influenza seasons in Ontario, Canada |
| Q60914665 | The respiratory microbiome and susceptibility to influenza virus infection |
| Q40222944 | Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness |
| Q47350852 | Update: Influenza Activity - United States, October 1-November 25, 2017. |
| Q38702418 | Update: Influenza Activity in the United States During the 2016-17 Season and Composition of the 2017-18 Influenza Vaccine |
| Q57122379 | Uptake and effectiveness of influenza vaccine in those aged 65 years and older in the United Kingdom, influenza seasons 2010/11 to 2016/17 |
| Q90423467 | Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol |
| Q89543170 | Vaccine effectiveness against influenza A(H3N2) and B among laboratory-confirmed, hospitalised older adults, Europe, 2017-18: A season of B lineage mismatched to the trivalent vaccine |
| Q47160827 | Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada |
| Q89892835 | Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season |
| Q47641366 | Vaccines for preventing influenza in the elderly. |
| Q64261266 | Viral infection detection using metagenomics technology in six poultry farms of eastern China |
| Q90092650 | Virological Surveillance of Influenza in the eight epidemic seasons after the 2009 pandemic in Emilia-Romagna (Northern Italy) |
| Q93344976 | [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] |
Search more.